The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives

Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy during women’s reproductive age. PCOS is a heterogeneous disorder featuring specific cardiometabolic properties. The association between the presence of metabolic disorders and PCOS supports the claim that the regulation of glycemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakic, Dejana, Jakovljevic, Vladimir, Jovic, Nikola, Bicanin Ilic, Marija, Dimitrijevic, Aleksandra, Vulovic, Tatjana, Arsenijevic, Petar, Sretenovic, Jasmina, Nikolic, Maja, Petrovich Fisenko, Vladimir, Bolevich, Stefani, Zarkovic, Gala, Joksimovic Jovic, Jovana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136160/
https://www.ncbi.nlm.nih.gov/pubmed/37189616
http://dx.doi.org/10.3390/biomedicines11040998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136160/
https://www.ncbi.nlm.nih.gov/pubmed/37189616
http://dx.doi.org/10.3390/biomedicines11040998

Ejemplares similares